
Keywords: ACEi, ACE inhibitor; ACR, albumin creatinine ratio; ARB, angiotensin II receptor blocker; ESRD, end-stage renal disease; GFR, glomerular filtration rate; RAAS, renin–angiotensin–aldosterone systemAlbuminuria; Renin–angiotensin system antagonist; Diabetic